ATTO Financials

Income Statement
MetricQ3 2026
Revenue
0
Cost of Revenue
0
Gross Profit
0
Operating Expenses
25.0M
R&D
20.3M
SG&A
4.7M
Operating Income
-25024000
EBITDA
-24776000
Net Income
-22271000
EPS (Basic)
$-0.76
EPS (Diluted)
$-0.76
Shares (Diluted)
29.4M
Attovia Therapeutics (ATTO) — Financials